1. Introduction
===============

Canine infectious respiratory disease (CIRD or kennel cough) is a multifactorial disease complex and the agents traditionally associated with this disease are *Bordetella bronchiseptica*, canine parainfluenza virus (CPIV), canine adenovirus (CAV), and canine herpesvirus (CHV). Recently, a novel canine respiratory coronavirus (CRCoV; [@bib7]) and *Streptococcus equi* subsp. *zooepidemicus* ([@bib1]) have also been found to be associated with the disease.

Within this microbial complex, *Mycoplasma* spp. are found to be ubiquitous in the upper respiratory tract of dogs and are thought to be normal flora ([@bib22], [@bib18]). However, mycoplasmas have also been the sole bacterial isolate in a number of clinical cases of canine respiratory disease, but unfortunately these isolates were not speciated and viral causes of CIRD were not investigated ([@bib12], [@bib11], [@bib4]). The involvement of *M. cynos* in CIRD has been noted for some time ([@bib19], [@bib21], [@bib22]). Evidence for this has been mounting recently, as [@bib3] found that *M. cynos* was the only mycoplasma significantly associated with canine respiratory disease. In addition, dogs entering a re-homing kennel that developed an antibody response to *M. cynos* were more likely to suffer respiratory disease ([@bib23]). *M. cynos* has been isolated from dogs with pneumonia ([@bib19], [@bib21], [@bib5]) and was particularly abundant in the most necrotic areas of the lung ([@bib5]). Furthermore, *M. cynos* was the only detected agent in a case of severe bronchopneumonia in a litter of young puppies which resulted in the deaths of some puppies, but which was resolved in the surviving littermates after the administration of appropriate antibiotics ([@bib25]).

Recently molecular epidemiological studies of isolates of the *Mycoplasma* species *M. bovis* ([@bib13], [@bib14]), *M. ovipneumoniae* ([@bib17]) *M. gallisepticum* and *M. synoviae* ([@bib9]) have been conducted using the genetic typing techniques amplified fragment length polymorphism (AFLP), random amplified polymorphic DNA (RAPD) and pulsed-field gel electrophoresis (PFGE). This is the first genetic typing study performed on *M. cynos*.

2. Materials and methods
========================

2.1. *Mycoplasma cynos* isolates
--------------------------------

*M. cynos* isolates cultured from respiratory samples from dogs with moderate to severe respiratory disease were identified from an earlier large study. Isolation and identification of these isolates has been previously described ([@bib3]). Briefly, bronchoalveolar lavage (BAL) and trachea samples were obtained from euthanized dogs from a re-homing centre with a history of endemic CIRD (population A). Alternately, BAL samples were taken from dogs with persistent coughs at a training centre (population B). Dogs were graded for respiratory signs prior to sampling or euthanasia. *M. cynos* was cultured on Mycoplasma media (Mycoplasma Experience) and identified by PCR specific for the 16S/23S rRNA intergenic spacer region. Cultures of the single-cloned *M. cynos* isolates were stored frozen at −70 °C.

The type strain *M. cynos* H381 NCTC10142 was obtained from the National Collection of Type Cultures (NCTC), Collindale, London.

2.2. Bacterial and viral screening
----------------------------------

Bacteriological screening of the samples has been previously described ([@bib1], [@bib2]). Briefly, BAL and trachea samples were inoculated onto MacConkey agar and two blood agar plates (incubated aerobically and anaerobically) and incubated at 37 °C. Gram positive, catalase negative, beta-haemolytic colonies were identified as streptococci and sero-grouped into Lancefield Groups, then identified to the species level with API 20STREP (Biomerieux). Oxidase positive colonies with typical *B. bronchiseptica* growth characteristics were identified as such with API 20NE.

Virus screening of the samples has been previously described ([@bib8]). Briefly, RNA and DNA were extracted from the respiratory tissue samples and PCR and reverse transcription-PCR were used to detect CPIV, canine herpesvirus (CHV), CAV, canine distemper virus (CDV), and CRCoV. In addition, RT-PCR for canine influenza virus (CIV) was carried out using primers AMP227F and AMP622R directed to the M gene ([@bib6]). Equine influenza virus (H3N8) served as a positive control.

2.3. Pulsed-field gel electrophoresis
-------------------------------------

Aliquots (20 ml) of stationary phase *M. cynos* culture (maximum absorbance *A* ~600~ of approximately 0.3) were used for PFGE analysis. Cells were harvested by centrifugation (3500 ×  *g* for 20 min at 4 °C), washed three times with PBS buffer with 10% (w/v) glucose and resuspended in 300 ml cold PBS/glucose buffer. Agarose plugs were made from a 1:1 mixture of 2% low-melting-point agarose (Biorad) and the cell suspension. Plugs were incubated in lysis buffer (10 mM Tris--HCl, 1 mM EDTA, 1% lauroyl sarcosine, 1 mg/ml proteinase K) for 48 h at 56 °C. Plugs were washed four times with Tris--EDTA buffer for 30 min at 4 °C. Slices (2 mm) were cut aseptically from plugs and equilibrated in restriction buffer (Promega) for 1 h. Subsequently, restriction digestion was performed by using 30 U of SmaI (Promega) for 16 h according to the manufacturer's instructions. The fragments were resolved on 1% pulsed field certified agarose (Biorad) gels using a CHEF-DRIII system (Biorad) at 6 V/cm, with a running time of 20 h at 14 °C; included angle of 120°; initial pulse time of 4 s; final pulse time of 40 s. Gels were stained with ethidium bromide (0.5 mg/ml) for 15 min, destained in distilled water for 1 h and photographed under UV light. A lambda ladder PFGE marker (Sigma) was used for fragment size determination. The Bionumerics package (Applied Maths) was used for gel analysis and dendrograms were produced using the Jaccard Coefficient and unweighted pair group method using arithmetic averages (UPGMA) cluster analysis.

2.4. RAPD
---------

The single primer Hum4 5′-ACGGTACACT-3′ ([@bib10]) was used for the generation of RAPD profiles. Amplification was performed in a 50-μl total reaction volume containing 100 ng of DNA sample, 10 mM Tris--HCl (pH 9.0), 1.5 mM MgCl~2~, 50 mM KCl, 0.1% Triton X-100, 0.2 mM each deoxynucleoside triphosphate, and 0.5 U of TaqGold (PerkinElmer). Cycling conditions included an initial denaturation step at 94 °C for 5 min, followed by 40 cycles of 94 °C for 15 s, 37 °C for 60 s and 72 °C for 90 s. The last cycle included a final elongation at 72 °C for 7 min. PCR products were resolved by electrophoresis on 10 cm 2% agarose gels at 60 mA for 1.5 h, stained with ethidium bromide and visualized under UV illumination. The Bionumerics package (Applied Maths) was used for gel analysis and dendrograms were produced using the Jaccard Coefficient and unweighted pair group method using arithmetic averages (UPGMA) cluster analysis.

3. Results
==========

3.1. Dogs
---------

Six dogs with moderate to severe respiratory disease from which *M. cynos* was isolated were identified from an earlier large study ([@bib3]). Four dogs were housed at a re-homing centre with a history of endemic CIRD (population A) and two dogs at a training centre (population B). All six dogs had respiratory disease with symptoms of either bronchopneumonia (respiratory score 5) or cough and nasal discharge (score 3). Trachea and/or BAL samples were taken from the dogs within 4 weeks of the first symptoms of CIRD. The dogs were 1--3 years old and of various breeds. The group consisted of entire and neutered males and females ([Table 1](#tbl1){ref-type="table"} ).Table 1Details of dogs with respiratory disease from which *M. cynos* isolates were cultured, and bacteriology and virology screening results of trachea (T) and bronchoalveolar lavage (BAL) samples.Dog[a](#tbl1fn1){ref-type="table-fn"}Age (years)Sex[b](#tbl1fn2){ref-type="table-fn"}BreedRespiratory score[c](#tbl1fn3){ref-type="table-fn"}Date sampledBacteriologyVirologyA-11MNGerman shepherd33 June 1999*B. bronchiseptica* and *M. spumans* in BAL; *M. cynos* in BAL and TNegativeA-22MStaffordshire bull terrier33 June 1999*B. bronchiseptica* and *Pasteurella* spp. in BAL; *M. cynos* in BAL and TCRCoV in TA-32MDalmatian511 October 1999*S. equi* subsp. *zooepidemicus* in BAL; *M. cynos* and *M. spumans* in BAL and TNegativeA-43FNMongrel524 February 2000*S. equi* subsp. *zooepidemicus*, *Enterococcus* spp., *Ureaplasma* spp. and *Escherichia coli* in BAL; *M. canis* and *M. cynos* in BAL and TCHV in BALB-11MNLabrador58 November 2000*M. cynos* in BAL[d](#tbl1fn4){ref-type="table-fn"}Negative[d](#tbl1fn4){ref-type="table-fn"}B-21FLabrador323 November 2000*M. cynos* in BAL[d](#tbl1fn4){ref-type="table-fn"}Negative[d](#tbl1fn4){ref-type="table-fn"}[^1][^2][^3][^4]

3.2. Bacteriology and virology screening
----------------------------------------

*M. cynos* was cultured from the BAL of each dog and also the trachea where that sample was available ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"} ).Table 2*Mycoplasma cynos* isolate source and genetic typing groups.Dog*M. cynos* isolate \#SourcePFGE groupRAPD groupA-1185BAL11210BAL11214BAL32253BAL11428T11429T11  A-2190BAL11417T11  A-3191BAL11  A-4312BAL11387T11  B-1491BAL22  B-2492BAL22510BAL31

Testing of BAL samples from the two dogs from the training centre (B-1 and B-2) was negative for the viruses CRCoV, CHV, CPIV, CAV, CDV and CIV. In addition, these samples yielded no bacterial growth except that of *M. cynos*. In comparison, the four dogs from the re-homing kennel had other bacteria cultured from the respiratory samples (see [Table 1](#tbl1){ref-type="table"}).

3.3. PFGE analysis of *M. cynos* isolates
-----------------------------------------

PFGE analysis of the *M. cynos* type strain and the 14 isolates from dogs with respiratory disease, resulted in six different PFGE profiles ([Fig. 1](#fig1){ref-type="fig"} ). The PFGE profiles consisted of 3--5 DNA bands, which ranged in size between approximately 6 and 425 kb. The PFGE profiles of the isolates can be divided by similarity into three groups. Group 1 contains 10 isolates and it is a genetically homogeneous group with at least 78% similarity; isolates 185, 190, 191, 210, 253, 312, 387, 417, 428, and 429 all form this group. These are all of the isolates from the population A dogs except isolate 214 from dog A-1.Fig. 1Similarity analysis of the *Sma*I PFGE profiles of the 14 *M. cynos* canine respiratory isolates from six dogs. Numbers 1--3 denote the groupings of similar profiles.

Group 2 contains 491 and 492 and these isolates are indistinguishable from each other but quite distinct to all the other isolates with only 28% similarity by cluster analysis. These isolates are from two different dogs from the training centre population (dogs B-1 and B-2).

The third group contains the type strain and isolates 510 and 214. The type strain and 510 are indistinguishable from each other, but 214 is distinctly different with only about 46% similarity to the other two. Isolate 510 was from dog B-2 while isolate 214 was from dog A-1.

3.4. RAPD analysis of *M. cynos* isolates
-----------------------------------------

When the same *M. cynos* isolates were subjected to analysis with RAPD with the primer Hum4, 12 different profiles were obtained ([Fig. 2](#fig2){ref-type="fig"} ). The profiles consisted of 3--13 bands which ranged in size between approximately 240 and 2200 bp. Two broad groups of similar isolates were formed. The type strain and the 11 isolates 185, 190, 191, 210, 253, 312, 387, 417, 428, 429 and 510 had similar profiles and are considered to be a homogeneous group with more than 68% similarity (group 1). This group comprises all of the isolates from the population A dogs, except for isolate 214, but also includes 510 from dog B-2 and the type strain.Fig. 2Similarity analysis of the profiles produced by RAPD with the primer Hum4. Numbers 1 and 2 denote the groupings of similar profiles.

Isolates 214, 491 and 492 formed a heterogeneous group about 60% similar to each other, but only about 26% similar to the group 1 isolates. These isolates are from dogs B-1, B-2 and isolate 214 from dog A-1.

The PFGE and RAPD grouping of isolates is summarised in [Table 2](#tbl2){ref-type="table"}.

4. Discussion
=============

This is the first genetic typing study of *M. cynos*. The isolates from each kennel were found to be genetically similar. Indeed, isolates from dogs that had been housed in the same kennel 4 and 8 months apart were found to be indistinguishable using both genetic analysis methods (isolates 417 and 191 from dogs A-2 and A-3, and isolates 429 and 387 from dogs A-1 and A-4, respectively). The dogs had stayed at the kennels for between 8 and 16 days. This may suggest that there is maintenance of *M. cynos* strains within a kennel situation. *M. cynos* can be isolated from the upper respiratory tract of healthy dogs ([@bib3]) and it is probable that some strains are passed between subsequent dogs, resulting in the survival of these strains. In addition, environmental survival may aid the continued existence of some strains. Although the environmental survival of *M. cynos* is not known, the environmental survival of other mycoplasma species varies from a week to several months ([@bib16]) and *M. cynos* can be isolated from the air ([@bib3]). Recently it has been shown that biofilm formation is important for persistence of mycoplasmas and may aid environmental survival ([@bib15]), it seems feasible that *M. cynos* may be able to persist in the kennel environment as an adherent biofilm layer.

The *M. cynos* type strain was isolated from the lung of a dog with CIRD in Denmark in 1971 ([@bib20]). This *M. cynos* type strain was indistinguishable by PFGE to isolate 510 from dog B-2 and was more than 68% similar by RAPD analysis to 11 of the *M. cynos* isolates from both kennels. The high degree of similarity of the type strain to these United Kingdom isolates from 1999 to 2000 suggests a low level of diversity of this organism in CIRD. However, this study also shows that some isolates have a relatively low level of similarity with each other (for example isolates 214, 491 and 492 appear to be dissimilar to the group 1 isolates). Indeed, this study suggests the potential for mixed *M. cynos* infections, as the same bronchoalveolar lavage sample from dog B-2 yielded *M. cynos* isolates 492 and 510, which are dissimilar strains. Similarly, the BAL sample from dog A-1 resulted in the culture of the 214 isolate which was dissimilar to the other isolates from this sample. A larger strain typing study of more isolates is required to consolidate these observations.

*M. cynos* was the only CIRD agent detected in two out of the six dogs (dogs B-1 and B-2). Similarly, recently [@bib25] described lethal bronchopneumonia in puppies where *M. cynos* was the only CIRD agent detected from the puppies. Mycoplasmas have been the sole bacterial isolate in a number of other cases of CIRD, but unfortunately these isolates were not speciated ([@bib12], [@bib11], [@bib4]). However, in the current study, both dogs were on a course of antibiotics preceding the sampling date (dog B-1 cephalosporin; B-2 erythromycin), which may have precluded the isolation of other bacterial agents. Likewise, in the case of [@bib25], the puppies had been treated with amoxicillin prior to isolation of *M. cynos* from the lung tissue.

*M. cynos* has also been previously implicated in canine respiratory disease along with other bacterial or viral pathogens ([@bib21], [@bib3], [@bib5]). This was also found in the current study as other respiratory pathogens apart from *M. cynos* were detected in the four dogs from the re-homing kennel, for example *B. bronchiseptica*, *S. equi* subsp. *zooepidemicus*, CHV and CRCoV. Multi-pathogen respiratory disease is commonly reported and it has been suggested that the pathogens may interact synergistically to produce disease ([@bib18]).

*Escherichia coli*, which was detected in one dog in the present study, has been previously isolated from BAL from a puppy with CIRD and was thought to be a contaminant ([@bib24]). This is likely to be the case in this study as *Enterococcus* spp. was co-isolated from the same sample. In addition, *M. spumans* was isolated from two dogs, one of which also had *M. canis* and *Ureaplasma* spp., however, these species were not found to be significantly associated with respiratory disease in dogs ([@bib3]).

In summary, the PFGE and RAPD genetic typing methods were in basic agreement and showed that many of the isolates were highly similar. Strain maintenance is suggested by strains which are indistinguishable by genetic typing, being isolated from dogs housed months apart within the same kennel. There was also a high degree of similarity of the *M. cynos* type strain (isolated from a dog with respiratory disease in Denmark in 1971) to at least one of these United Kingdom isolates, which suggests possible conservation of pathogenic strains of *M. cynos*.

We thank Dr. V. Chalker for the *M. cynos* isolates and The Royal Veterinary College Bacteriology Lab for bacteriological screening of dog respiratory samples. We thank Mitesh Patel for his assistance with the molecular typing.

[^1]: A: re-homing centre; B: training centre.

[^2]: N: neutered.

[^3]: 3: cough and nasal discharge; 5: bronchopneumonia.

[^4]: No trachea sample available.
